Skip to main content
. 2014 Dec 15;111(52):18637–18642. doi: 10.1073/pnas.1415607112

Fig. 5.

Fig. 5.

Loss of Rbm38 significantly reduces the tumor penetrance in p53-heterozygous mice. (A) The level of Rbm38, p53, and actin was determined in p53+/− and Rbm38−/−; p53+/− MEFs. (B) Kaplan–Meyer survival curves of p53+/− (n = 24) and Rbm38−/−; p53+/− (n = 21) mice (P = 0.371 by log-rank test). (C) Comparison of tumor-free mice between a cohort of p53+/− and Rbm38−/−; p53+/− mice.